Published: July 29, 2010
BioScrip to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference
ELMSFORD, N.Y. - (BUSINESS WIRE) - BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at
the BMO Capital Markets 10th Annual Focus on Healthcare
Conference on Thursday, August 5, 2010 at the Sheraton New York Hotel &
Towers in New York City.
BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman,
and Richard M. Smith, President and Chief Operating Officer will present
at 11:15 AM ET (Eastern Time). Investors may access a live audio web
cast of BioScrip's presentation at the following link: http://www.bmocm.com/conferences/2010healthcare/webcast/.
A web cast replay of the presentation can also be accessed via
BioScrip's website at www.bioscrip.com,
under the "Investors Section" .
About BioScrip, Inc.
BioScrip, Inc. (www.bioscrip.com)
(Nasdaq: BIOS) is a national provider of specialty pharmacy and home
care products and services that partners with patients, physicians,
hospitals, healthcare payors and pharmaceutical manufacturers to provide
clinical management solutions and delivery of cost-effective access to
prescription medications. Our services are designed to improve clinical
outcomes for chronic and acute healthcare conditions while controlling
overall healthcare costs.
Forward Looking Statements-Safe Harbor
This press release may contain statements which constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including statements regarding the
intent, belief or current expectations of the Company, its directors, or
its officers with respect to the future operating performance of the
Company, Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from
those in the forward-looking statements as a result of various factors.
Important factors that could cause such differences are described in the
Company's periodic filings with the Securities and Exchange Commission.

BioScrip, Inc.
Stanley G. Rosenbaum, 952-979-3768
Executive
Vice President and Chief Financial Officer
srosenbaum@bioscrip.com
or
In-Site
Communications
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News